Top compounds associated with response to LGALS9B


Feature Type Standardized
Nominal ANOVA
mRNA SCH-79797 CTRPv2 pan-cancer AAC 0.08 0.03
mRNA MLN2480 CTRPv2 pan-cancer AAC -0.12 0.03
mRNA ML258 CTRPv2 pan-cancer AAC -0.085 0.03
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.076 0.03
mRNA IPR-456 CTRPv2 pan-cancer AAC -0.085 0.03
mRNA AT7867 CTRPv2 pan-cancer AAC -0.078 0.03
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.076 0.03
mRNA ML210 CTRPv2 pan-cancer AAC -0.073 0.03
mRNA LY-2183240 CTRPv2 pan-cancer AAC -0.07 0.03
mRNA COL-3 CTRPv2 pan-cancer AAC -0.081 0.03
Download CSV